The exceptions utilized brain tissue from PSP patients (Darricau et al., 2024; Darricau et al., 2022) or viral vectors encoding for multiple tau mutations (Beckman et al., 2021; Beckman et al., 2024; Jiang et al., 2024). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.